EcoDrugPlus

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSPEMG00000019097
Gene Symbol: APEX1
3 Cross references
212 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s-Type

Ensembl ID : ENSPEMG00000007278
Gene Symbol: LOC102903566
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSPEMG00000015300
Gene Symbol: ALOX5
3 Cross references
220 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSPEMG00000000576
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSPEMG00000027000
Gene Symbol: AVPR1A
3 Cross references
264 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSPEMG00000023110
Gene Symbol: AVPR1B
3 Cross references
134 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSPEMG00000008325
Gene Symbol: AVPR2
3 Cross references
231 Possible Orthologues:

Aromatase

Ensembl ID : ENSPEMG00000020167
Gene Symbol: LOC102926053
3 Cross references
315 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSPEMG00000018651
Gene Symbol: AURKB
1 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSPEMG00000020333
Gene Symbol: AURKC
1 Cross references
96 Possible Orthologues:

Bcl-2-Like Protein 2

Ensembl ID : ENSPEMG00000028029
Gene Symbol: LOC102925823
3 Cross references
64 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSPEMG00000021179
Gene Symbol: BACE1
3 Cross references
217 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).